1. Introduction
===============

Gastric cancer is the second most common cause of cancer death worldwide \[[@b1-ijms-13-13308],[@b2-ijms-13-13308]\]. About one million patients are newly diagnosed with gastric cancer each year, with 700,000 deaths each year \[[@b1-ijms-13-13308]\]. It is known that gastric cancer can be caused by the interaction between environmental factors and genetic variations \[[@b3-ijms-13-13308]--[@b5-ijms-13-13308]\]. As an environmental factor, Helicobacter pylori (*H. pylori*) infection plays an important role in the development of gastric cancer. However, only a small proportion of *H. pylori* carriers develop gastric cancers. Such clinical diversity indicates that there are likely to be other factors in gastric carcinogenesis, including genetic susceptibility of the host \[[@b6-ijms-13-13308]--[@b8-ijms-13-13308]\].

Aird *et al.* were the first to notice the correlation between gastric cancer and blood group A \[[@b9-ijms-13-13308]\]. Since then, the relationship between ABO blood groups and carcinogenesis or progression of human tumors has been reported by many investigations, including increased breast cancer risk in blood group A \[[@b10-ijms-13-13308]\]. In a hospital-based case-control study, increased pancreatic cancer risk among persons with blood type A \[[@b11-ijms-13-13308]\], and increased ovarian cancer risk in women with blood group A than in others was reported \[[@b12-ijms-13-13308]\]. However, the results regarding the relationship between blood group A and gastric cancer were inconsistent \[[@b9-ijms-13-13308],[@b13-ijms-13-13308]--[@b15-ijms-13-13308]\].

Meta-analysis is a well-established method that can pool the data from smaller inconclusive studies \[[@b16-ijms-13-13308]\]. Compared to individual studies, the data yielded from meta-analysis disclosed greater statistical power and property for genetic risks analysis \[[@b17-ijms-13-13308]\]. To understand the correlation between ABO blood groups and the risk of developing gastric cancer, we conducted a case-control study of 1,045 cases of gastric cancer from Shanghai Ruijin Hospital, and 53,026 healthy blood donors from Shanghai blood center. Moreover, we searched the Pubmed database and combined them with our own research data in order to perform an overall meta-analysis on the relationship between ABO blood groups and the gastric cancer risk. Current study provides a systematic knowledge on the correlation among human ABO blood groups, *H. pylori* susceptibility and gastric cancer risk.

2. Results
==========

2.1. The Case-Control Study
---------------------------

A cohort case of 1,045 gastric cancer was collected from Shanghai Ruijin Hospital. Among them, 438 cases (41.91%) were blood group A, 233 cases (22.30%) group B, 289 cases (27.66%) group O and 85 cases (8.13%) group AB. As a control, a cohort of 53,026 healthy blood donors was collected from the local blood bank. Among them, 16,595 individuals (31.30%) were blood group A, 13,443 (25.35%) group B, 18,329 (34.57%) group O and 4,659 (8.78%) group AB. In comparing the gastric cancer group with the healthy controls, it becomes evident that the risk of gastric cancer in blood groups A was significantly higher than that in non-A groups (OR = 1.34, 95% CI 1.25--1.44). The individuals with blood group O showed a significant reduced risk of gastric cancer (OR = 0.80, 95% CI 0.72--0.88). The people with blood group B showed a significantly reduced risk of gastric cancer, relative to non-B group (OR = 0.88, 95% CI 0.78--0.99). The difference of gastric cancer risk between the blood group AB and the non-AB groups was not significant (OR = 0.93, 95% CI 0.75--1.14).

We compared the distribution of ABO blood groups in *H. pylori* positive cases and *H. pylori* negative cases in the gastric cancer group. In 67 cases of *H. pylori* positive gastric cancer patients, 35 cases (52.2%) were blood group A, 17 (25.4%) group B, 13 (19.4%) group O, and 2 (3.0%) group AB. By contrast, in 48 cases of *H. pylori* negative gastric cancer cases, 15 (31.3%) were blood group A, 11 (22.9%) group B, 16 (33.3%) group O, and 6 (12.5%) group AB. The ratio of *H. pylori* infection in blood group A cases was significantly higher than that in non-A blood group cases (OR = 1.42; 95% CI 1.05--1.93). Compared with non-O blood group, individuals with blood group O showed a reduced risk of *H. pylori* infection (OR = 0.71; 95% CI 0.46--1.10). People with blood group AB also showed a modestly reduced risk of *H. pylori* infection, compared with non-AB blood groups (OR = 0.41; 95% CI 0.12--1.38). The difference of *H. pylori* infection ratio between Blood group B and non-B blood groups was not significant (OR = 1.06; 95% CI 0.75--1.50).

2.2. Meta-Analysis
------------------

Through extensive research, a total of 24 original articles covered 15,843 gastric cancer cases and 1,421,740 controls were put into the meta-analysis. One of the articles contains two populations \[[@b18-ijms-13-13308]\]. Meanwhile, our Asian cohort collected from Shanghai Ruijin Hospital was included in the meta-analysis ([Figure 1](#f1-ijms-13-13308){ref-type="fig"}, [Table 1](#t1-ijms-13-13308){ref-type="table"}). The meta-analysis resulted in the following: the risk of gastric cancer in a blood group A individual was significantly higher than that in a non-A group (OR = 1.11, 95% CI 1.07--1.15), and the blood group O individuals showed a significant reduced risk of gastric cancer, compared with the non-O individuals (OR = 0.91, 95% CI 0.89--0.94). However, no significant difference was found when blood group B was compared with non-B groups (OR = 0.97, 95% CI 0.91--1.04) or when blood group AB was compared with non-AB groups (OR = 0.95, 95% CI 0.87--1.03). The forest plots for the relation between ABO blood groups and the risk of gastric cancer were presented in [Figure 2](#f2-ijms-13-13308){ref-type="fig"} to [Figure 5](#f5-ijms-13-13308){ref-type="fig"}.

2.3. Meta-Regression Analyses
-----------------------------

To evaluate the heterogeneity among the parameters, we performed meta-regression analysis on publication time, country (geographical factor), study design, and the proportion of ABO blood group individuals in cases and controls (sample constitution factors) ([Table 2](#t2-ijms-13-13308){ref-type="table"}). For blood group B, the geographic factor (Coef. = 0.17, *p* = 0.015) and sample constitution factor (Coef. = 2.39, *p* = 0.001) were the reasons for heterogeneity. For blood group O, sample constitution factor (Coef. = 2.39, *p* = 0.001) was the source of heterogeneity (Coef. =1.14, *p* = 0.017).

Furthermore, we evaluated stratum-specific odds ratios, and the stratum-specific estimation for geographical region showed that OR for blood group B in Asian people is 1.141, 95% CI (1.065--1.122); in Europe, OR is 0.885, 95% CI (0.825--0.948); in America, OR is 0.981, 95% CI (0.887--1.085) and in mixed areas, OR is 0.928, 95% CI (0.757--1.138). Moreover, the overall OR for blood group B after stratum-specific analysis by geographical region is 0.978, 95% CI (0.929--1.029). The stratum-specific odds ratio for sample constitution in blood group B showed that, in Group One, OR is 4.822, 95% CI (4.505--5.160); while in Group Two, OR is 0.456, 95% CI (0.433--0.479). The overall OR for blood group B after stratum-specific analysis by sample constitution, then, is 0.978, 95% CI (0.929--1.029). Furthermore, the stratum-specific odds ratio for sample constitution in blood group O shows that, in Group One, OR is 6.443, 95% CI (6.315--6.575); in Group Two, OR is 0.265, 95% CI (0.254--0.276), and the overall OR for blood group O after stratum-specific analysis is 0.832, 95% CI (0.809--0.856).

2.4. Publication Bias
---------------------

We used Begg's test or Egger's test to evaluate the publication bias. There were no significant publication bias for blood group A (Begg's test, *p* = 0.83; Egger's test, *p* = 0.77), blood group B (Begg's test, *p* = 0.75; Egger's test, *p* = 0.07), blood group O (Begg's test, *p* = 0.08, Egger's test, *p* = 0.27) and blood group AB (Begg's test, *p* = 0.21; Egger's test, *p* = 0.14). The Begg's funnel plot for the relation between ABO blood groups and the risk of gastric cancer are shown in [Figure 6](#f6-ijms-13-13308){ref-type="fig"}.

3. Discussion
=============

The relationship between the ABO blood group system and the incidence of tumor has been noticed for many years. Recently, Iodice *et al.* reported that the incidence risk of pancreatic cancer in blood group O individuals was significantly reduced compared with that in non-O group (RR = 0.79, 95% CI 0.70--0.90) in Europeans \[[@b19-ijms-13-13308]\]. Meanwhile, they investigated the relationship between ABO blood groups and other kinds of cancer, but failed to confirm the relationship between ABO blood groups and gastric cancer. In our case-control study, we found a significant relationship between ABO blood groups and gastric cancer. The risk of gastric cancer in blood groups A was significantly higher than that in non-A groups.

A systematic meta-analysis helps researchers to summarize studies on specific topics. Since meta-analysis is a combination of multiple studies, it is less influenced by separate findings from a single study. In addition, meta-analyses reveal higher statistical power than traditional single studies. Regarding the effect of ABO blood groups on the risk of gastric cancer, we performed a meta-analysis combined with our case-control study from a large cohort. The meta-analysis indicated that the risk of gastric cancer in blood group A individuals was significantly higher than that in non-A group individuals (OR = 1.11, 95% CI 1.07--1.15), whereas the individuals with blood group O showed a significantly reduced risk of gastric cancer, compared with the non-O individuals (OR = 0.91, 95% CI 0.89--0.94). Odds ratios are commonly reported in the medical literature as the measure of association between exposure and outcome \[[@b20-ijms-13-13308]\]. In this present study, the OR values of the relationship between blood group A and gastric cancer was in the range of 1.1--1.5, suggesting a weak association. The OR value of the relationship between blood group O and gastric cancer is in the range of 0.8--0.9, which also suggests a weak association. However, our meta-analysis failed to prove any relationship between blood group B or blood group AB with the gastric cancer risk. Regarding the heterogeneity of the publication language, data quality and data source, there are some limitations in meta-analysis. Therefore, the researchers need to search more articles including English articles and non-English articles in order to make their meta-analysis more reliable for guiding clinical work.

The association between blood group A and gastric cancer has been mentioned in the studies of several groups \[[@b9-ijms-13-13308],[@b13-ijms-13-13308],[@b14-ijms-13-13308]\]. In regards to the possible explanations for the increased incidence of gastric cancer in blood group A individuals, Roberts *et al.* proposed that individuals with blood group A were more susceptible to pernicious anemia, compared with non-A blood group individuals \[[@b21-ijms-13-13308]\]. A pernicious anemia individual is more prone to gastric cancer \[[@b18-ijms-13-13308]\]. A clinical study demonstrated that altered gastric secretary function may be related to the ABO blood group. Compared to individuals with blood group A, the individuals of blood group O produced more free acid in their stomachs. The mean value of plasma pepsinogen in individuals with blood group O (564 units/mL) was higher than that in individuals with blood group A (494 units/mL) \[[@b22-ijms-13-13308]\]. One study indicated that the immune-reaction to tumors in individuals with blood group A was reduced compared with the non-A blood group individuals \[[@b12-ijms-13-13308],[@b23-ijms-13-13308]\]. Recently, one paper published in *Nature* journal indicated that the erythrocyte receptor-ligand pair is essential for erythrocyte invasion in the pathogenesis of malaria. They found that Ok blood group antigen, a kind of blood group antigen, is a receptor for erythrocyte invasion of the parasite \[[@b24-ijms-13-13308]\]. This discovery suggested that individuals with the A blood group antigen may be more susceptible to *H. pylori* invasion. Therefore, we further analyzed the infection status in our gastric cancer cohort and found that the ratio of *H. pylori* infection in blood group A cases was significantly higher than that in non-A blood group cases. Recently, Nakao *et al*. analyzed the ABO genotype and the risk of gastric cancer, atrophic gastritis and *H. pylori* infection, and proposed that the risk for gastric cancer, atrophic gastritis and *H. pylori* infection was increased in AA genotype \[[@b25-ijms-13-13308]\]. This finding is consistent with our data. *H. pylori* plays an important role in the development of gastric ulcer and gastric cancer. *H. pylori* is a Gram negative bacteria, which can be divided into cytotoxin-associated antigen (CagA) and vacuolating cytotoxin (VacA) positive strains, as well as CagA and VacA negative strains. CagA positive *H. pylori* suggest a considerably increased risk of gastric cancer \[[@b26-ijms-13-13308]\]. The adhesion molecule system of *H. pylori* helps the bacteria colonizing in stomach mucosa. The most important adhesion molecular is blood group antigen-binding adhesion A (BabA). Adherence by *H. pylori* increases the risk of gastric disease. Animal experiments revealed that BabA could stimulate the inflammatory cells to release more interleukin-8, CCL5 proinflammatory cytokines and precancer-related factors (CDX2 and MUC2) \[[@b27-ijms-13-13308]\]. Since inflammatory response to *H. pylori* infection plays an important role in cellular proliferation and gastric mucosal damage, the upregulation of proinflammatory cytokines in people with chronic gastritis may be an important clinical implication in gastric carcinogenesis.

4. Experimental Section
=======================

4.1. Case-Control Study
-----------------------

The ABO blood group information of 1,045 cases of hospitalized gastric cancer was from Shanghai Ruijin Hospital between 2002 and 2010, with age 25 to 90, median 60 years old. Among them, 709 cases are male and 336 cases are female. Of them, 115 cases obtained *H. pylori* infection information through 13C urea breath test before operation. The diagnosis of gastric cancer was confirmed histologically in all patients. The control group was composed of 53,026 healthy blood donors in 2010 from Shanghai central blood bank. Informed consent for participation in the study was obtained from all subjects with approval by the ethics committee of Ruijin Hospital.

Pearson's chi-square test was used to compare the distribution of ABO blood groups between gastric cancer patients and controls. Odds ratios (OR) and 95% confidence intervals (CI) were used to evaluate the relationship between ABO blood groups and gastric cancer. All statistical analyses were performed with SPSS (Version 15.0; SPSS Inc.: Chicago, IL, USA). *p* \< 0.05 indicated statistically significant differences.

4.2. Meta-Analysis and Statistics
---------------------------------

We comprehensively searched the Pubmed database for all English literatures from 1953 to end of 2010. We combined the terms "stomach neoplasms \[MeSH\] OR gastric neoplasms \[tiab\] OR stomach cancer \[tiab\] OR gastric cancer\[tiab\] OR stomach carcinoma\[tiab\] OR gastric carcinoma \[tiab\] OR gastric tumor \[tiab\]" and "ABO blood group system \[MeSH\] OR Blood Group \[tiab\] OR Blood group antigens \[tiab\]." The selection of articles was accomplished independently by two researchers (Wang and Liu), and discrepancies were discussed with the third researcher (Yu), until consensus was reached. The literatures that meet the following criteria were included in the meta-analysis: (1) the study was either a case-control study, or a nested case-control study; (2) the study reported the definite numbers of individuals with blood groups A, B, O, and AB in gastric cancer cases and controls. Non-English articles, review articles, or articles which were involving the mechanism study were excluded from the study. We used a standardized protocol to extract the following data from each publication, including the first author, year of publication, study design, source of the control group, country in which the study was performed and the percentage of ABO blood groups in cases and controls ([Table 1](#t1-ijms-13-13308){ref-type="table"}) \[[@b9-ijms-13-13308],[@b13-ijms-13-13308],[@b18-ijms-13-13308],[@b19-ijms-13-13308],[@b26-ijms-13-13308],[@b28-ijms-13-13308]--[@b45-ijms-13-13308]\].

Q and Higgins I^2^ statistics were used to examine heterogeneity among studies. In Q statistic, *p* value less than 0.05 means a heterogeneity. The extent of heterogeneity was evaluated by I^2^, which was documented as the percentage (*I*^2^ = 0%--25%, no heterogeneity; *I*^2^ = 25%--50%, moderate heterogeneity; *I*^2^ = 50%--75%, high heterogeneity; *I*^2^ = 75%--100%, extremely high heterogeneity) \[[@b46-ijms-13-13308],[@b47-ijms-13-13308]\]. Fixed-effects model (Mantel Haenszel) or random-effects model (Dersimonian and Laird) was used depending on the heterogeneity between studies. The fixed-effects model was used if there was no significant heterogeneity, otherwise, the random-effects model was used \[[@b46-ijms-13-13308]\]. To estimate the one or more covariates related to heterogeneity, meta-regression, as an extension to random-effects meta-analysis, was employed. Publication time is a continuous variable. Whole data are divided into two case-control studies and other studies. Geographical region is divided into Asia, Europe, America and other areas. As for a sample constitution, we first computed the mean of the proportion of people with different ABO blood groups in all individuals. The proportion of persons with different ABO blood groups was higher than the mean that was deemed as Group One, while the proportion of individuals with different ABO blood groups was lower than the mean that was deemed as Group Two. The overall effect was assessed by *Z* test. Funnel plots and Egger's regression asymmetry test or Begg's test were used to probe for publication bias \[[@b48-ijms-13-13308],[@b49-ijms-13-13308]\]. Forest plots were used for graphic display. A *p* value of \<0.05 was considered statistically significant. All data were analyzed with STATA (Version 11.0; Stata Corp.: College Station, TX, USA).

5. Conclusions
==============

In conclusion, the present study confirmed that gastric cancer risk is increased in individuals with blood group A, as opposed to those in non-A blood groups. The individuals with blood group O showed a significant reduced risk of gastric cancer comparing with non-O blood groups. The susceptibility of blood group A individuals to gastric cancer may be partially attributed to an increased risk of *H. pylori* infection. This study implied that there must be a host genetic susceptibility for gastric cancer. However, the exact molecular mechanism underlying the relationship between ABO blood groups, *H. pylori* infection and gastric cancer needs to be further explored.
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###### 

The literature about ABO blood groups and gastric cancer included in the meta-analysis.

  First author                                               Publication year   Study type     Source of controls          Reference              Gastric cancer   Healthy control                                                                     
  ---------------------------------------------------------- ------------------ -------------- --------------------------- ---------------------- ---------------- ----------------- ----- ------ ------ --------- ------ --------------------- ------ ------
  Hollander [\*](#tfn1-ijms-13-13308){ref-type="table-fn"}   1953               NA             NA                          [@b22-ijms-13-13308]   704              53.1              7.5   36.2   3.12   4518      45.1   [@b9-ijms-13-13308]   41.7   4.25
  Aird                                                       1953               CC             Hospital/voluntary donors   9                      3632             44.8              7.8   44.5   2.89   3632      39.8   8.3                   48.6   3.19
  Wallace                                                    1954               CC             Voluntary donors            [@b23-ijms-13-13308]   299              34.8              10    53.2   2      7418      33.5   11                    51.9   3.55
  Koster                                                     1955               CC             Voluntary donors            [@b24-ijms-13-13308]   413              51.3              11    34.1   3.87   14304     44     11                    40.6   4.5
  Buckwalter                                                 1956               CC             Voluntary donors            [@b27-ijms-13-13308]   879              45.9              9.2   42.1   2.84   6313      41.6   9                     45.8   3.58
  Buckwalter                                                 1958               CC             Voluntary donors            [@b25-ijms-13-13308]   908              45.8              9.3   42.2   2.75   49979     42.3   9.4                   44.8   3.5
  Eisenberg                                                  1958               CC             Voluntary donors            [@b29-ijms-13-13308]   892              45                12    38.6   4.04   75904     40.3   12                    43.7   4.3
  Beasley                                                    1960               CC             NA                          [@b13-ijms-13-13308]   746              46.9              8.7   41.7   2.68   8084      41.1   9.7                   45.4   3.8
  Doll                                                       1960               CC             Hospital                    [@b30-ijms-13-13308]   857              45.7              8.8   42.2   3.26   10000     42.2   8.9                   45.8   3.13
  Doll                                                       1961               CC             Hospital/voluntary donors   [@b34-ijms-13-13308]   229              37.6              9.6   52     0.87   860       39.3   11                    47.7   2.44
  McConnell                                                  1961               NA             NA                          [@b36-ijms-13-13308]   105              40                16    41.9   1.9    610       43     9.8                   44.6   2.62
  Newman                                                     1961               CC             Hospital/voluntary donors   [@b31-ijms-13-13308]   118              51.7              8.5   36.4   3.39   1261      40.6   11                    44.7   3.33
  Hoskins                                                    1965               CC             Voluntary donors            [@b26-ijms-13-13308]   146              34.9              16    46.6   2.74   5236      34.2   12                    49.7   3.9
  Hoskins                                                    1965               CC             Hospital/voluntary donors   [@b26-ijms-13-13308]   223              36.3              10    47.5   5.83   4222      37.7   11                    47.2   3.79
  Glober                                                     1971               CC             Hospital/voluntary donors   [@b37-ijms-13-13308]   1680             45.9              8.5   42     3.57   43026     42.2   8.9                   45.8   3.09
  Ray                                                        1980               CC             Voluntary donors            [@b35-ijms-13-13308]   584              21.1              42    29.1   7.71   8821      24     34                    33.9   8.15
  Parsonnet                                                  1997               NCC            cohort members              [@b38-ijms-13-13308]   103              41.8              13    43.7   1.94   139       31.7   12                    50.4   5.76
  Lossowska                                                  1999               CC             Voluntary donors            [@b39-ijms-13-13308]   417              42.9              NA    30.2   NA     454       36.6   NA                    35.9   NA
  Klaamas                                                    1999               CC             Voluntary donors            [@b32-ijms-13-13308]   171              42.7              23    26.9   7.02   298       35.2   21                    34.9   9.4
  Posilović                                                  2003               CC             Hospital                    [@b33-ijms-13-13308]   62               37.1              NA    30.7   NA     75        34.7   NA                    46.7   NA
  Sharara                                                    2006               CC             Voluntary donors            [@b40-ijms-13-13308]   15               46.7              20    26.7   6.67   104       25     20                    51     3.85
  Hajj                                                       2007               CC             Hospital/voluntary donors   [@b41-ijms-13-13308]   152              50                8.6   36.8   4.61   18972     35.6   14                    47     3.88
  Iodice                                                     2010               CC             Hospital                    [@b42-ijms-13-13308]   301              39.2              9.3   45.9   5.65   15058     40.2   12                    43.9   4.2
  Qiu                                                        2010               CC             Hospital                    [@b43-ijms-13-13308]   474              26.2              24    41.4   8.44   404       27.2   26                    40.1   6.44
  Edgren                                                     2010               Cohort study   Voluntary donors            [@b28-ijms-13-13308]   688              48.1              9.6   35.8   6.54   1089022   44     11                    39.4   5.31
  this study                                                                    CC             Voluntary donors                                   1045             41.9              22    27.7   8.13   53026     31.3   25                    34.6   8.79

Note: The data was cited in Aird's article; Abbreviations: not available (NA); case-control study (CC); nested case-control study (NCC).

###### 

Meta-regression analysis of ABO blood groups with covariates of interest.

  Variable              Blood group A   Blood group B    Blood group O                                                                                         
  --------------------- --------------- ---------------- --------------- ------- -------- --------------- ------- ----------- ------- ---------------- ------- -----------
  Publication year      0.001           (−0.001,0.002)   0.55            0.586   −0.003   (−0.01,0.001)   −1.97   0.067       0.001   (−0.001,0.002)   1.29    0.261
  Area                  −0.03           (−0.09,0.03)     −1.09           0.292   0.17     (0.03,0.30)     2.74    **0.015**   −0.01   (0.06,0.04)      −0.4    0.693
  Study type            0.08            (−0.04,0.20)     1.4             0.181   −0.21    (−0.48,0.06)    −1.64   0.122       −0.03   (−0.15,0.08)     −0.61   0.548
  Source of control     −0.01           (−0.06,0.05)     −0.28           0.785   0.08     (−0.04,0.20)    1.35    0.198       −0.01   (−0.06,0.04)     −0.32   0.755
  Sample constitution   0.88            (−0.06,1.83)     1.97            0.066   2.39     (1.11,3.66)     3.99    **0.001**   1.14    (0.23,2.06)      2.65    **0.017**

Abbreviations: Coef., coefficient; CI, confidence interval.

[^1]: These authors contributed equally to this work.
